News
Strive Asset Management has raised $750 million to pursue the strategy while Ramaswamy runs to be Ohio’s governor.
Biotech execs express concerns over FDA changes, NIH cuts, and Trump's tariffs. Industry confidence low amid poor funding ...
4don MSNOpinion
In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...
This week ended up as a pretty active one for large startup financings. AI and biotech were the biggest areas for funding, ...
Hosted on MSN1mon
11 Stocks to Buy After the Biotech BloodbathThe key to biotech is finding companies with lots of cash and promising ... a market value under $200 million—compared with about $100 million of cash. Jefferies analyst Maury Raycroft favors ...
Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...
The 10 most innovative biotech companies of 2025 are leveraging AI ... Trial results published in 2024 showed 100% accuracy of the DarwinOncoTarget tool at predicting response to drugs called ...
Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...
DarwinHealth was honored as one of the 10 most innovative biotech companies in the Most Innovative ... Trial results published in 2024 showed 100% accuracy of the DarwinOncoTarget tool at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results